New curcumin paper below [1].
It's been 46 years since Richard Nixon declared war on cancer.
Each October, an enormous amount of money is collected for breast cancer-related purposes. Not all goes to BCa research, but a lot does. (Too bad about the other 'hormonal' cancers - ovarian, cervical, endometrial - & of course, PCa.) & yet, still no BCa cure.
In recent years, it has become common to pin the blame on cancer cells with stem-like properties, but when I was diagnosed, many PCa experts disputed that they even existed - no-one had seen a PCa progenitor cell & no-one knew what to look for.
The big success stories of recent years - Zytiga & Xtandi - follow in the Huggins tradition by targeting the androgen receptor [AR], either directly (as with Casodex, & now Xtandi) or by starving AR of hormones (as with castration, DES, Lupron, & now Zytiga). Alas, PCa progenitor cells lack AR.
They also do not produce PSA. PCa studies tend to measure success based on the percentage of participants who achieve >50% PSA reduction.
Is the new curcumin study a good one? At this stage, I'll use anything that might target PCa stem-like cells. And there are plenty of other reasons to use curcumin.
It's a Chinese-American cell study. "Curcumin can suppress HuPCaSC {human prostate cancer stem cell} proliferation and invasion in vitro ..."
I use Longvida [CurcuBrain] because of it's bioavailability [2] [3].
-Patrick
[1] ncbi.nlm.nih.gov/pubmed/291...
Genet Test Mol Biomarkers. 2017 Nov 27. doi: 10.1089/gtmb.2017.0179. [Epub ahead of print]
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs.
Zhang H1, Zheng J1, Shen H2, Huang Y3, Liu T1,4, Xi H3, Chen C1.
Author information
1
1 Shanghai Geriatric Institute of Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine , Shanghai, China .
2
2 Department of Urology, Beijing Friendship Hospital , Capital Medical University, Beijing, China .
3
3 Shanghai Tenth People's Hospital, Medical School, Tongji University , Shanghai, China .
4
4 Department of Pathology, Yale University School of Medicine , New Haven, Connecticut.
Abstract
AIMS:
Curcumin can suppress human prostate cancer (HuPCa) cell proliferation and invasion. However, it is not known whether curcumin can inhibit HuPCa stem cell (HuPCaSC) proliferation and invasion.
MATERIALS AND METHODS:
We used methyl thiazolyl tetrazolium and Transwell assays to examine the proliferation and invasion of the HuPCaSC lines DU145 and 22Rv1 following curcumin or dimethyl sulfoxide (control) treatment. The microRNA (miRNA) expression levels in the DLK1-DIO3 imprinted genomic region in the cells and in tumor tissues from patients with PCa were examined using microarray and quantitative PCR.
RESULTS:
The median inhibitory concentration of curcumin significantly inhibited HuPCaSC proliferation and invasion in vitro. The miR-770-5p and miR-1247 expression levels in the DLK1-DIO3 imprinted gene cluster were significantly different between the curcumin-treated and control HuPCaSCs. Overexpression of these positive miRNAs significantly increased the inhibition rates of miR-770-5p- and miR-1247-transfected HuPCaSCs compared to the control miR-Mut-transfected HuPCaSCs. Last, low-tumor grade PCa tissues had higher miR-770-5p and miR-1247 expression levels than high-grade tumor tissues.
CONCLUSIONS:
Curcumin can suppress HuPCaSC proliferation and invasion in vitro by modulating specific miRNAs in the DLK1-DIO3 imprinted gene cluster.
KEYWORDS:
DLK1-DIO3 imprinted gene cluster microRNAs; curcumin; human prostate cancer stem cells (HuPCaSCs); proliferation and invasion
PMID: 29172709 DOI: 10.1089/gtmb.2017.0179
...
[2] youtube.com/watch?v=Bw025Ih...
...
[3] swansonvitamins.com/now-foo...